SanBio Company Limited (TYO:4592)
Japan · Delayed Price · Currency is JPY 1,050.00
+42.00 (4.17%)
Jul 15, 2026, 3:30 PM JST
SanBio Company Market Cap
SanBio Company has a market cap or net worth of 81.96 billion as of July 15, 2026. Its market cap has decreased by -56.58% in one year.
Market Cap
81.96B
Enterprise Value
69.14B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,050.00
Market Cap Chart
Since April 8, 2015, SanBio Company's market cap has increased from 77.34B to 81.96B, an increase of 5.98%. That is a compound annual growth rate of 0.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 81.96B | -37.85% |
| Dec 30, 2025 | 131.88B | 147.58% |
| Dec 30, 2024 | 53.27B | 15.83% |
| Dec 29, 2023 | 45.99B | -5.12% |
| Dec 30, 2022 | 48.47B | -7.07% |
| Dec 30, 2021 | 52.16B | -24.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 171.41B |
| PeptiDream | 130.93B |
| Nxera Pharma | 85.11B |
| Oncolys BioPharma | 75.43B |
| Cuorips | 39.68B |
| Healios K.K. | 35.24B |
| Japan Tissue Engineering | 26.23B |
| Renascience | 20.65B |